A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated

Lung Cancer

Volumn 47, Issue 3, 2005, Pages 373-380

  Chen, Yuh Min ^a,b   Perng, Reury Perng ^a   Shih, Jen Fu ^a   Tsai, Chun Ming ^a   Whang Peng, Jacqueline ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cisplatin; Gemcitabine; Non small cell lung cancer; Vinorelbine

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOCETAXEL; GEFITINIB; GEMCITABINE; METOCLOPRAMIDE; NAVELBINE; PACLITAXEL; PLATINUM;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INOPERABLE CANCER; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTOPENIA;

EID: 13844298523     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.08.007     Document Type: Article

References (26)

1. Non-small cell lung cancer collaborative group. Chemotherapy in non-small cell lung cancer, a meta-analysis using updated data in individual patients from 52 randomized trials. Br Med J 1995;311:899-909.
2. Y.M. Chen, R.P. Perng, K.Y. Yang, T.W. Liu, C.M. Tsai, and J.M. Liu A multi-center phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small cell lung cancer Chest 117 2000 1583 1589
3. S. Palmeri, V. Leonardi, V. Gebbia, M.T. De Bella, F. Ferrau, and G. Faillu Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial Lung Cancer 34 2001 115 123
4. E. Laack, T. Mende, J. Benk, A. Chemaissani, J. Scholtze, and C. Lorenz Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial Euro J Cancer 37 2001 583 590
5. E. Bajetta, S. Chiara Stani, D. De Candis, P. Bidoli, L. Mariani, and N. Zilembo Gemcitabine plus vinorelbine as first-line chemotherapy in advanced non-small cell lung carcinoma: a phase II trial Cancer 89 2000 763 768
6. G. Krajnik, A. Mohn-Staudner, J. Thaler, R. Greil, S. Schmeikal, and F. Marhold Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer Ann Oncol 11 2000 993 998
7. S. Niho, K. Kubota, K. Goto, H. Ohmatsu, T. Matsumoto, and R. Kakinuma Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study Br J Cancer 87 2002 1360 1364
8. E. Laack, T. Mende, H. Durk, M. Kneba, N. Dickgreber, and T. Welte Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial Euro J Cancer 38 2002 654 660
9. P. Comella, G. Frasci, N. Panza, L. Manzione, V. Lorusso, and G. Di Rienzo Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group J Clin Oncol 17 1999 1526 1534
10. P. Ginopoulos, N.S. Mastronikolis, J. Giannios, A. Karana, V. Siabi, and F. Karvelas A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC) Lung Cancer 23 1999 31 37
11. D.H. Johnson Evolution of cisplatin-based chemotherapy in non-small cell lung cancer: a historical perspective and the Eastern Cooperative Oncology Group experience Chest 117 Suppl 1 2000 133 137
12. Y.M. Chen, R.P. Perng, J.F. Shih, Y.C. Lee, C.S. Lee, and C.M. Tsai A randomized phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated Br J Cancer 90 2004 359 365
13. World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication no. 48. Geneva (Switzerland): World Health Organization; 1979.
14. R. Simon, R.E. Wittes, and S.S. Ellenberg Randomized phase II clinical trials Cancer Treat Rep. 69 1985 1375 1381
15. J.H. Schiller, D. Harrington, C.P. Belani, C. Langer, A. Sandler, and J. Krook Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer New Engl J Med 346 2002 92 98
16. H. Raftopoulos, R.J. Gralla, E. Bria, and A. Eid Assessing the role of chemotherapy in advanced non-small cell lung cancer (NSCLC): a comprehensive review of large randomised trials 1991-2001 Proc Am Soc Clin Oncol 21 2002 a1284
17. M.Q. Baggstrom, M.A. Socinski, T.A. Hensing, and C. Poole Third-generation chemotherapy regimens (3GR) improve survival over second-generation regimens (2GR) in stage IIIB/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature Proc Am Soc Clin Oncol 21 2002 a1222
18. P. Ginopoulos, E. Kontomanolis, D. Kardamakis, M. Sougleri, S. Rathosis, and A. Karana A phase II study of non-platinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer Lung Cancer 38 2002 199 203
19. Y.M. Chen, R.P. Perng, Y.C. Lee, J.F. Shih, C.S. Lee, and C.M. Tsai Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated Ann Oncol 13 2002 108 115
20. V. Georgoulias, E. Papadakis, A. Alexopoulos, X. Tsiafaki, A. Rapti, and M. Veslemes Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial Lancet 357 2001 1478 1484
21. J.Y. Douillard, D. Lerouge, A. Monnier, J. Bennouna, A.M. Haller, and X.S. Sun Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study Br J Cancer 84 2001 1179 1184
22. D. Isla, R. Rosell, J.J. Sanchez, A. Carrato, E. Felip, and C. Camps Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer J Clin Oncol 19 2001 1071 1077
23. C. Gridelli, C. Gallo, F.A. Shepherd, A. Illiano, F. Piantedosi, and S.F. Robbiati Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 21 2003 3025 3034
24. P.J. Souquet, E.H. Tan, J. Rodrigues Pereira, R. Van Klaveren, A. Price, and U. Gatzemeier GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients Ann Oncol 13 2002 1853 1861
25. P. Comella, G. Frasci, N. Panza, L. Manzione, G. De Cataldis, and R. Cioffi Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group J Clin Oncol 18 2000 1451 1457
26. V. Alberola, C. Camps, M. Provencio, D. Isla, R. Rosell, and C. Vadell Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial J Clin Oncol 21 2003 3207 3213